Seladelpar Improves Cholestasis and Pruritus in Obeticholic Acid and Fibrate-experienced Patients With Primary Biliary Cholangitis
Recommended Citation
Gordon SC, Proehl S, Pratt D, Qi X, Levy C, and Crittenden DB. Seladelpar improves cholestasis and pruritus in obeticholic acid and fibrate-experienced patients with PBC. Clin Gastroenterol Hepatol 2026.
Document Type
Article
Publication Date
1-21-2026
Publication Title
Clinical gastroenterology and hepatology
Abstract
With the recent announcement of the withdrawal of obeticholic acid (OCA) in the United States (U.S.), there is a need to transition patients with primary biliary cholangitis (PBC) taking OCA to alternative therapy.
PubMed ID
41577065
ePublication
ePub ahead of print
COinS
